z-logo
open-access-imgOpen Access
Inflammatory Myofibroblastic Tumor: A Rarely Seen Submucosal Lesion of the Stomach
Author(s) -
Deniz Arslan,
Şeyda Gündüz,
Deniz Tural,
Mükremın Uysal,
Ali Murat Tatlı,
Cumhur İbrahim Başsorgun,
Gülsüm Özlem Elpek,
Hasan Şenol Çoşkun,
Hakan Bozcuk,
Burhan Savaş
Publication year - 2013
Publication title -
case reports in oncological medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.173
H-Index - 7
eISSN - 2090-6714
pISSN - 2090-6706
DOI - 10.1155/2013/328108
Subject(s) - medicine , pathology , stomach , lesion , histopathological examination , resection , mesenchymal stem cell , surgery
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal benign tumor which is generally seen in children and in young adults. It is especially located in the lungs. In histopathological examination, neoplastic fusiform cells originating from a subtype of accessory immune system cells which are called fibroblastic reticulum cells are seen (Kouichi and Youichirou, 2008). Although IMT is histopathologically benign, imaging methods show its tendency for local recurrence and invasion. In most of the cases, it may not be possible to make a distinction whether it is malign or benign. Complete surgical resection is the most important treatment method. In this study, we have discussed the findings of our case having a gastric submucosal located IMT in light of the current literatures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom